Bumper Offer - Urjas oil Just @ Rs. 1
Telmizem Beta-50 Tablet is an allopathic medicine The correct dosage of Telmizem Beta-50 Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Telmizem Beta-50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Telmizem Beta-50 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Telmizem Beta-50 Tablet safe for pregnant women?
Telmizem Beta-50 Tablet shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Telmizem Beta-50 Tablet safe during breastfeeding?
Telmizem Beta-50 Tablet has been seen to have minimal side effects on breastfeeding women.
What is the effect of Telmizem Beta-50 Tablet on the Kidneys?
Telmizem Beta-50 Tablet is not harmful for kidneys.
What is the effect of Telmizem Beta-50 Tablet on the Liver?
Telmizem Beta-50 Tablet may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Telmizem Beta-50 Tablet on the Heart?
Telmizem Beta-50 Tablet has very mild side effects on the heart.
Telmizem Beta-50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmizem Beta-50 Tablet unless your doctor advises you to do so -
Is this Telmizem Beta-50 Tablet habit forming or addictive?
Telmizem Beta-50 Tablet does not cause addiction.
Interaction between Food and Telmizem Beta-50 Tablet
Some foods when eaten with Telmizem Beta-50 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Telmizem Beta-50 Tablet
Taking alcohol with Telmizem Beta-50 Tablet can be dangerous.
Yes, Telmizem Beta-50 Tablet is safe to use, if taken in prescribed quantity and duration as advised by the doctor. However, few side effects are observed such as dizziness, depression, tiredness, bloating, and stomach pain. If you feel any of the above- mentioned side effects after taking medicine, please consult your doctor right away and follow his/her instructions.
No, You should not discontinue Telmizem Beta-50 Tablet on your own. It may cause some serious side effects if you suddenly stop taking this medication. You are recommended to consult your doctor before discontinuing this medicine on your own.
Rarely Telmizem Beta-50 Tablet causes hair loss. However, if you experience hair loss after taking this medicine then inform to doctor right away and follow his/her instructions.
Yes, Telmizem Beta-50 Tablet can increase the blood sugar level. If you experience elevated levels of blood sugar after taking this medicine then inform the doctor and follow his/her instructions.
Yes, Telmizem Beta-50 Tablet can affect fertility. As per clinical studies, fertility defect was found in animal models, human clinical trial on fertility is still pending. You should take precaution while taking medicine during pregnancy. However, it is best to inform the doctor before taking these two medicines together.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
